Prevalence of Substandard and Falsified Essential Medicines-Reference-Cited by-同舟云学术

Prevalence of Substandard and Falsified Essential Medicines

Published:2018-08-10 Issue:4 Volume:1 Page:e181685
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Mackey Tim K.¹²³

Affiliation:

1. Division of Infectious Diseases and Global Public Health, Department of Anesthesiology, School of Medicine, University of California, San Diego

2. Global Health Policy Institute, San Diego, California

3. World Health Organization Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector, University of Toronto, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/4/e181685/17313367/mackey_2018_ic_180043.pdf

Reference10 articles.

1. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.;Mackey;BMC Med,2013

2. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.;Mackey;Am J Trop Med Hyg,2015

3. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.;Hamilton;Health Policy Plan,2016

4. Prevalence and estimates of economic factors associated with substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis.;Ozawa;JAMA Netw Open,2018

5. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.;Nayyar;Lancet Infect Dis,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review;Frontiers in Medicine;2024-07-18

2. SUBJECTIVE ANALYSIS OF QUALITY INDICATORS OF MEDICINAL PRODUCTS;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-12-20

3. Recall of substandard medicines in Brazil during the period 2010–2018;BMC Health Services Research;2023-03-10

4. The quality of antiretroviral medicines: an uncertain problem;BMJ Global Health;2023-03

5. Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey;Therapeutic Advances in Drug Safety;2023-01